1159613-24-7

Basic information

• Product Name: 3'-Hydroxy Darunavir
• Synonyms: 3'-Hydroxy Darunavir
• CAS NO: 1159613-24-7
• Molecular Formula: C27H37N3O8S
• Molecular Weight: 563.66298
• Product Categories: Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals
• Mol File: 1159613-24-7.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3'-Hydroxy Darunavir(CAS DataBase Reference)
• NIST Chemistry Reference: 3'-Hydroxy Darunavir(1159613-24-7)
• EPA Substance Registry System: 3'-Hydroxy Darunavir(1159613-24-7)

Safety Data

• Hazardous Substances Data: 1159613-24-7(Hazardous Substances Data)

Usage

Description

3'-Hydroxy Darunavir is a metabolite of Darunavir (D193500), which is a novel inhibitor of the human immunodeficiency virus (HIV) protease. 3'-Hydroxy Darunavir plays a significant role in the treatment of HIV infection and has also been identified as a COVID-19-related research product, indicating its potential relevance in the study and management of the coronavirus disease.

Uses

Used in Pharmaceutical Industry:
3'-Hydroxy Darunavir is used as an active pharmaceutical ingredient for the treatment of HIV infection. As a metabolite of Darunavir, it contributes to the inhibition of HIV protease, which is essential for the replication of the virus within the host cells. This action helps in suppressing the viral load and managing the progression of the disease in HIV-positive individuals.
Used in COVID-19 Research:
3'-Hydroxy Darunavir is also used as a research compound in the context of COVID-19. Its role as a protease inhibitor, along with its metabolite status, makes it a valuable candidate for investigating potential therapeutic strategies against the coronavirus. The compound may provide insights into the development of new antiviral drugs or the repurposing of existing medications to combat COVID-19.